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Pharmaceuticals stocked in Authorized Medical/Dental Allowance Lists
(AMAL/ADAL) have an ongoing problem of expiration. Due to short shelf-life,
Prepositioned War Reserve (PWR) pharmaceuticals inventory require constant monitoring
to maintain medical support readiness. The problem associated with pharmaceuticals is the
high cost of replacement and disposal. Numerous expired drugs were found in AMALs
as a result of inaccurate inventory procedures. Current practices of the Medical Logistics
Company were investigated and research was conducted for solutions on the
pharmaceutical inventory problem. Cost-benefit studies for a stability program and a bar
code system show potentially cost-effective measures to solve the shelf-life problem. The
financial as well as the beneficial outcomes of increasing drug stability and implementing
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GLOSSARY
Allowance . The quantity of equipment and supplies
distributed throughout the MEF to provide a capability to
perform the health care mission.
Authorized Medical Allowance List (AMAL) . The
authorized allowances of medical equipment and consumable
supplies required to accomplish health care support under
combat conditions.
AMAL Supply . The list of consumable supplies that are
required to support a predetermined patient care load
associated with a specific health care function i.e.,
sickcall, x-ray, operating room, etc.
D-Dav Significant Drugs . Drugs carried by the Federal
Medical Supply System that has been reviewed by a tri-service
ad hoc committee of medical subject matter experts and reduced
to those drugs and dosage levels which are considered
essential for wartime casualty care. The drugs constitute the
minimal requirements, adequate but austere, for the general
medical and surgical care of casualties should D-day occur.
Defense Priorities and Allocation System (DPAS) . A
system of priorities and allocations with industry resources
to assure the timely availability of supplies to meet current
national defense requirements.
Medical Logistics Data (MLD) . An accounting system for
PWR medical and dental assets.
IX
Module . The packaging of equipment or supplies which
make an AMAL into a functional unit that is designed to
establish a specific health care capability or to treat a
predetermined number of patients.
Marine Corps Standard Supply System (M3S) . A
subsection of SASSY at the Medlog level that performs Class
VIII ordering functions.
National Stock Numbers (NSN) . Federal stock
classification of materiel for stocking and requisitioning
purposes
.
Prepositioned War Reserve Stock (PWRS) . That portion
of the war reserve material requirement that approved plans
state should be positioned or issued to the user prior to
hostilities, at or near the point of planned use, to ensure
timely support of a specific project or designated force
during the initial phase of war, pending arrival of
replenishment shipments.
Rotation . This involves the issuance of theater war
reserve stock to peacetime operating medical treatment
facilities (MTFs)
.
Shelf-life . The period of time beginning with the date
of manufacture/cure/assembly and terminated by a date by which
the item must be used or subjected to inspection/test/
restorative disposal action. For medical commodities, the term
shelf-life refers only to expiration dated (potency) items.
x
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The Medical Logistics Company (Medlog) maintains and
manages the Authorized Medical/Dental Allowance List
(AMAL/ADAL) . The AMAL/ADAL lists the items needed to provide
medical support for a Marine Expeditionary Force (MEF) for 60
days in the event of war. The AMAL 1 contains the
pharmaceuticals required to treat a number of casualties or
perform a specified number of treatment procedures. Since the
AMAL is maintained ready for combat support, all
pharmaceuticals allocated to the MEF are classified as
prepositioned war reserved (PWR) material. The PWR
pharmaceuticals are distributed within different AMAJ.s
(Appendices A and B)
.
The major problem with pharmaceuticals is expiration due
to degradation in potency and sterility. Readiness requires
stockage even though there is a recurring financial loss due
to outdating. Loss also occurs because of deficient inventory
controls and inadequate tracking and distribution methods.
Further losses occur due to the lack of training for Medlog
personnel. There is a high turnover of personnel because of
1AMAL/ADAL will be referred to as AMAL for the purpose of
brevity.
short tour rotation. Currently, the sole means by which Medlog
can reduce financial loss is by requesting shelf-life
extension from the Food and Drug Administration (FDA) via the
Naval Medical Logistics Command (NAVMEDLOGCOM)
.
The shelf-life constraint of pharmaceuticals has seriously
complicated combat medical logistics planning by increasing
mobilization costs in an era of shrinking Department of
Defense (DoD) budget. If DoD does not procure the required
pharmaceuticals, combat readiness is reduced; on the other
hand, if required levels are stock-piled, high dollar values
of pharmaceuticals are disposed of each year as their shelf-
life expires (Petroski, 1987).
B. STATEMENT OF THE PROBLEM
An analysis of the supply procedures, methods, and
supporting documents of Medlog was conducted in January 1991
by the Field Supply and Maintenance Analysis Office Two at
Marine Corps Base, Camp Pendleton. Similar analyses are
conducted periodically to determine compliance with applicable
regulations and to report readiness conditions. The analysis
found that AMAL blocks were issued to Fleet Marine Force (FMF)
units deployed to the Persian Gulf between August and November
1990 without conducting pre-deployment inventories. Asset
Locator Reports (ALRs) , which list AMAL block contents, were
not provided due to the short-fused mobilization. FMF units
were advised to contact Medlog if blocks contained expired
pharmaceuticals (USMC Field Supply Office Two, 1991) . A review
of the ALRs during the analysis revealed that many
pharmaceuticals in the AMAL blocks had expired.
The report further indicated that 411 (91%) of 449
National Stock Numbers (NSN) in the Bulk Warehouse had
discrepancies, such as excesses, shortages and inaccurate
locations. An inventory review of 92 NSNs packed in AMAL
blocks scheduled for deployment noted 55 (60%) disparities
between quantities listed on ALRs and the warehouse locator
cards within the containers . Two AMAL blocks were opened,
which revealed two types of discrepancies: (1) on hand items
were not in the ALR, and (2) the blocks contained expired
items. In one block, 15 (28%) out of 53 items showed
disparities. In the other block, disparities were noted in 15
(33%) of 46 items.
A review of the Medlog Database System revealed that
stocks of 151 drugs had expired prior to July 1989, without
documentation for FDA extension requests or FDA approved
extensions. The total value of the expired pharmaceuticals was
$587,656.97. Furthermore, there were no records to
substantiate that annual inventories had been conducted in
1990, as required. It was noted in the analysis that
adjustments were made to rectify discrepancies such as:
inventory gain of $1,875,640; inventory loss of $145,355;
administrative gain of $802,892; administrative loss of
$57,355; and miscellaneous loss of $354,573. This indicates
that current files and records lack a viable inventory control
program (USMC Field Supply Office Two, 1991.) Finally, proper
storage procedures to protect against damage and deterioration
of material were disregarded (USMC Field Supply Office Two,
1991) . The report concluded:
The current operating procedures within the unit's
supply account reflect significant deficiencies. Of
specific note were the findings in the areas of Inventory
Control and Deployed Unit Support. It is of paramount
importance for any supply operation to effectively control
all assets assigned to their account and ensure timely
identification, requisition and receipt of asset
shortages. Failure to properly accomplish these primary
supply functions obscures the asset picture and creates an
atmosphere conducive to mismanagement and
misappropriation. Further, the lack of effective supply
procedures could have a devastating effect on the unit's
ability to conduct its assigned mission.
C. OBJECTIVE OF THE RESEARCH
This research will analyze Medlog' s inventory problems
involving critical pharmaceuticals that are expensive, subject
to deterioration, and require special storage. The research
will focus on shelf-life and drug stability in planning and
managing PWR pharmaceuticals. In addition, the thesis will
analyze the cost of using a bar coding system to more
accurately track expiration dates and location of
pharmaceuticals in AMAL blocks.
Many techniques are used to compare alternative solutions.
One of these is tradeoff analysis. Like any business entity,
cost containment is a major objective. In a constrained
resource environment, especially in a period of budget
reduction and increased oversight by both in-house and
congressional agencies, the optimal allocation of funding
resources is a major goal of Medlog. The results of this study
will indicate the strengths and weaknesses of the current
pharmaceutical inventory management policies and suggest
future policy alternatives.
D. RESEARCH QUESTIONS
The primary question is "How can the inventory cost of PWR
pharmaceuticals be minimized?"
Subsidiary questions are as follows:
1 . What are the strengths and weaknesses of the current
system?





The thesis examines the problems in achieving inventory
readiness for pharmaceuticals and analyzes alternative
inventory management policies to resolve existing problems . It
also examines shelf-life extension, drug stability, and
inventory actions to better track expiration dates. All of the
measures will help reduce disposal costs. Alternatives will be
analyzed to optimize the distribution of pharmaceuticals, to
increase accuracy of records, and eventually to minimize
annual operating costs . The study is limited to
pharmaceuticals prepositioned with the Medlog. Specific
methods to reduce inventory costs and to improve the
efficiency of inventory management will be addressed.
F. ORGANIZATION OF THE THESIS
The remainder of the thesis is organized as follows: In
Chapter II, background literature provides an overview of the
role and operations of Medlog and the problems with
pharmaceuticals. Chapter III investigates current programs to
manage the shelf-life of pharmaceuticals and analyzes
alternative actions. Chapter IV discusses the tradeoffs, cost-
benefit and sensitivity analyses of alternative methods. The
final chapter offers conclusions and recommendations for
better managing pharmaceutical inventories in the FMF
.
II. BACKGROUND OF PWR PHARMACEUTICALS
A. OVERVIEW
PWR pharmaceuticals are part of AMALs required to
accomplish the war time health care mission from D-day to
D+60. This means that each MEF will hold enough AMAL
consumables, including deteriorative medicines, to support a
MEF requirement of 60 days. D-day pharmaceuticals are
designated by the military as critical during initial
mobilization or deployment of Navy and Marine Corps forces.
The quantities in the AMAL are set for the initial 60 days,
before normal replenishment shipments arrive.
B. MEDICAL SUPPORT OF THE FMF
The AMAL allowances are capable of treating 20,000
casualties in 60 days. The AMAL is reviewed every six years
for adequacy to meet support needs . The Navy Medical and
Dental Material Bulletin provides current information on drug
stability, safety, suspensions, extensions and other
pharmaceutical information. Medlog, in conjunction with MEF
units, is responsible for maintaining adequate AMAL
inventories to ensure that the appropriate level of medical
support can be delivered when required.
AMALs are inventoried annually. At this periodic review,
pharmaceuticals which expire prior to the next review are
highlighted and are checked for candidacy in the FDA Shelf-
life Extension Program. Items that are not listed under the
extension program may be redistributed to other military
treatment facilities as a no cost transfer or in an item-for-
item trade for newer stocks (Marine Corps Order 6700. 2D,
1991) .
C. MISSION AND TASKS OF MEDLOG
Medlog provides the organizational structure for
centralizing AMAL maintenance and management within the Force
Service Support Group (FSSG) . The Commanding Officer, Supply
Battalion, FSSG is responsible for directing and guiding the
operation of Medlog. Figure II-A provides the organizational
chart of Medlog. The mission is to provide for the receipt,
storage, management, and issue of medical supplies and
equipment to support the AMALs assigned to medical and dental
elements of the force. Medlog manages the AMAL inventory
before it is issued to using units.
One of the major tasks is to maintain PWR pharmaceuticals
for combat support. Maintenance of pharmaceuticals includes
inventory management, building required blocks for training
and operations, maintaining 60 days of supply (DOS) for
pharmaceuticals and pursuing disposal through authorized
disposal sites for expired drugs. Disposal goes through Pine
Bluff Arsenal or Defense Reutilization and Marketing Office
(DRMO)
. Unexpired drugs are redistributed to other users.
Command i ng
















































Figure II-A Medical Logistics Co. Organizational Chart
Medlog has five sections for AMAL management: Contingency,
Data, Procurement, Bulk Warehouse, and Deployable Units. The
Contingency section maintains the AMAL blocks for
pharmaceutical stockpiling. Data maintains ALRs and forecasts
information for shelf-life tracking. Deployable Units
maintains AMAL blocks for training. They track inventory
before and after each training exercise. Both Contingency and
Deployable Units use the ALR to update deficiencies. Data
section updates the database and forwards a "picking ticket"
to the Procurement section for replenishment. If the item is
in stock at the Bulk Warehouse, the item is restocked. If not
in stock, a purchase order is placed. Figure II-B shows the
flow of inventory and replenishment of items.
D. OPERATING PROCEDURES
The total current assets of bulk and modular stock items
on hand are recorded in the PWR report. This report is the
primary management tool to track deficiencies. It is
considered a best estimate. The report identifies both pending
requisitions and FDA Extension Program nominations.
A procurement clerk is designated to monitor PWR
pharmaceuticals. The PWR report is used to determine over
stockage or shortages by NSNs . To avoid interruption of supply
support, total current pharmaceuticals from the PWR report
plus substitute items and FDA extension nomination drugs can
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Figure II-B Inventory/Replenishment Flow Diagram
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forecast report of expiring items are used to project stocks
for the next 12 months. Pharmaceuticals must have at least 12
months shelf-life to be deployable. Items with less than this
shelf-life are retained to support other FMF units. These
drugs are highlighted and replenishment is ordered if the drug
is not under FDA shelf-life extension nomination.
E. THE PROBLEM WITH PHARMACEUTICALS
The fundamental problem that burdens the inventory-
management of PWR pharmaceuticals is deterioration or limited
shelf-life. D-day significant pharmaceuticals have varying
expiration dates, which cause a complex inventory problem.
Some pharmaceuticals are packaged in the same manner as used
for civilian medical facilities. This poses storage problems
for the DoD (Swope, Drill, and Chappell, 1982) . The quick,
convenient, ready to use drug forms expire or deteriorate
quicker than drugs packaged in vials or in powder form.
Although ready to use drugs are more efficient in the civilian
sector, the shorter shelf-life inhibits stockpiling for
mobilization purposes (Swope, Drill, and Chappell, 1982)
.
There are other types of medical consumables contained in
AMALs which also have expiration dates, including: x-ray
films, laboratory test reagents, and certain bandages. The
current system of procuring AMAL quantities, storing and
allocating them to AMALs, and disposing and replacing when
12
they expire is an expensive process (Swope, Drill, and
Chappell, 1982)
.
The average shelf-life of pharmaceuticals is three years.
Therefore, a significant amount of inventory value must be
replaced annually to meet medical support readiness (Petroski,
1987) . Medlog spends approximately 2.0 million dollars a year
to replace outdated material. Contracting for pharmaceuticals
is the responsibility of the Defense Logistics Agency (DLA)
through the Defense Personnel Support Center (DPSC) . DPSC
specifies that dated assets be contracted for a shelf-life not
less than 36 months.
A portion of PWR pharmaceuticals are categorized as
military unique. Examples include Atropine and other nerve gas
antidotes. These require unique packaging and storage
requirements. Petroski stated that all military unique
pharmaceuticals have a shelf-life less than three years.
Taking into account procurement lead time, AMAL location
placement and inventory, many will be near expiration prior to
the next periodic review. Tracking these items is a labor
intensive process and 2.0 million dollars worth of
pharmaceuticals await disposition every year. If Medlog can
not issue or redistribute the stock to other Military
Treatment Facilities (MTFs) or Navy and Marine Corps units,
there is a financial loss.
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F. RELATED STUDIES
A literature survey was conducted to assess studies
regarding the issue of dated pharmaceuticals. Previous
research on the subject includes studies regarding stability
for specific drugs, shelf-life characteristics, alternatives
to extend shelf-life, quality assurance in inventory
management, and logistics planning and policy making
recommendations for mobilization. Most of the studies were
directed towards either stability for specific drugs or
overall pharmaceuticals management policy.
1 . Logistics Planning and Mobilization
Petroski (1987) examined inventory readiness for drugs
as a critical element of logistics support. He recommended
that DPSC should seek exemption from the Small Business Act
when procuring PWR material and should seek maximum dating.
The Small Business Act fosters competition, but discourages
larger drug manufacturers from conducting research to increase
shelf-life of military unique drugs. Industry needs incentives
to pursue research to technologically improve stability.
Petroski recommended that DoD should also pursue the
possibility of Allied assistance in maintaining PWR stocks.
A medical mobilization study on the management of
dated drugs was conducted by Swope, Drill, and Chappell,
(1982) . The report noted different policies implemented by the
different services. The authors recommended that coordination
14
in planning would make mobilization tasking more efficient and
help to maintain readiness
.
2 . Quality Assurance and Management of Pharmaceuticals
Treece and Rosnick (1977) investigated existing
regulations and policies on the management of dated
pharmaceuticals to determine whether patients received
adequate care. They concluded that regulation guidance is
inadequate to properly ensure patient welfare. They found
improper management of expiration-dated pharmaceuticals at the
lowest level . The incidence of expired items at the activity
level were higher than the acceptable levels mandated by
higher authority. Treece and Rosnick recommended that Army
regulations be amended to provide specific guidance for
operating activities to ensure optimum quality in an Army
health care activity.
This recommendation seems to pertain to Medlog,
considering the number of expired items found during the
recent deployment to the Persian Gulf. According to Treece and
Rosnick, the acceptable level per standards is .005 or one
expired item in every 200 lines of stock inspected. From the
supply analysis conducted at Medlog f the average expired rate
was approximately 0.31. The expired rate was determined by
dividing the number of expired drugs by the total number of
expiration-dated drugs in an inventory block.
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Treece and Rosnick also recommended a semi-automated
data entry system, similar to the system Medlog uses - key
entry computer to store a data base that includes NSN,
expiration date, and placement. They also recommended a
periodic inventory of pharmaceuticals. This is currently the
method used at Medlog.
T. Brown (1989) addressed the methodology for
selecting and maintaining potency and dated drugs . He
concluded that the current policy for PWR pharmaceuticals,
involving extension, storage and mobilization, is
fundamentally sound at the strategic level
.
3. Shelf-life and Procurement of Medical Items
A method discussed by Baker and Jernigan (1989) uses
the Medical Acquisition Shelf-life System (MASS) model to
assist procurement analysts in evaluating alternative bids for
stocked medical shelf-life material . The MASS is used by DPSC
to evaluate bids and make recommendations for procurement. The
decision aid uses historical data to calculate life cycle
costs by considering purchase price and administrative costs,
including transportation, handling, storage, disposal and
replacement costs . The model balances shelf-life stability
against higher purchase prices. They recommended updating the
data used for evaluation annually.
16
4 . Stability Studies
Stability studies conducted by Brown and Sleeman
(1980) indicated that stability is dependent upon the active
ingredient, temperature, and other factors such as pH,
packaging and additives . They concluded that the shelf-life
for nerve agent antidotes would be maximized when packaged in
glass at pH 2.7 and stored at 5 degrees centigrade. In
addition, adding propylene glycol improves the stability of
the drug
.
The above studies indicate that drug stability and
general policies regarding the management of PWR
pharmaceuticals have been conducted. This thesis will reflect
on the conclusions and recommendations made by others and
focus on improving inventory practices to manage expiration-
dated pharmaceuticals in AMALs . This study will reemphasize
how drug stability studies could be centrally implemented at
the DoD level and use transactional methods of inventory
control at the Medlog level. Cost and benefits of the proposed
solutions will be compared with the current system. Based on
this comparison, implementation of a bar code system to track
expiration dates accurately will be introduced to improve the
overall inventory management
.
The next chapter will investigate the current system
and the current programs that provide guidance on shelf-life
management . Analysis of proposed alternatives will then be
presented to relate how the existing practice can be improved
17
to fulfill the mission of Medlog and serve the FMF more
effectively, efficiently, and responsibly.
III. RESEARCH AND CONCEPTUAL FRAMEWORK
This chapter will look into the current Medlog methodology
for PWR pharmaceuticals management. The process encompasses
procedures as mandated by directives from Marine Corps Orders
(MCOs) and Navy Medicine manuals as well as practices handed
down as a result of the organizational culture. The process is
drawn from standard operating procedures (SOPs) written by
previous Medlog commanders to be consistent with MCOs and
manuals. The current practices will be assessed first. Then
potential alternatives for dealing with the issue of shelf-
life will be identified. Finally, the chapter will look into
a transactional method for Medlog to monitor shelf-life,
redistribution and disposition of pharmaceuticals.
A. ANALYSIS OF THE CURRENT SYSTEM
Pharmaceuticals and medical supplies are classified as
Class VIII Material. The collective allowance of medical and
dental materiel forms the AMAL . Medical supplies are obtained
from the Supported Activities Supply System (SASSY) management
unit, referred to as SMU. SMU is responsible for Class VIII
ordering. These orders are coordinated with the Marine Corps
Standard Supply System (M3S) , a supply subsection at the
Medlog level.
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Pharmaceutical stock levels are computed by the
Procurement section. All bulk shelf-life items are stored in
a separate and distinct area in a warehouse. Each item is
separated and maintained by NSN and lot number in a bulk
location. The pharmaceuticals and other dated items are
identified by the Federal Stock Classification of 6505 and
6550. The expiration dates are closely monitored. Prior to
moving pharmaceuticals from bulk to modular AMAL, shelf-life
must be at least one year. Items with less than one year
shelf-life are checked for FDA extendibility . Some
pharmaceuticals are automatically extended by FDA. These items
are published in the Navy Medical and Dental Bulletin (a
NAVMEDLOGCOM Publication) . Items that have expired are
immediately moved to an expired location awaiting disposition.
Medlog does not have a fully automated tracking system.
The Data section tracks pharmaceuticals based on lot number
and expiration date. This section prints out a forecast of
expiration by lot number. However, once pharmaceuticals move
to AMAL blocks, tracking by ALR is labor intensive and
oftentimes erroneous, as revealed in the Supply Analysis
discussed in Chapter I.
The current inventory policy includes a periodic review of
items when they are received, annually for AMAL, and pre- and
post-training for deployable AMAL blocks. Inventory teams are
organized within the Contingency and Deployable Unit sections.
This practice involves physical counts and requires strict
20
validation of inventory counts. These counts are translated
into reports and printouts . AMAL blocks are taken out of the
warehouse location and counted item by item. The inventory
involves two teams. Team A takes out items and counts them.
Team B counts the items again and puts them back on warehouse
block locations
.
After each inventory, large boxes of pharmaceuticals with
less than 12 months shelf-life are removed from AMAL blocks
for disposition. Medlog has several options. Medlog may send
them to the U.S. Army Depot, Pine Bluff, Arkansas for
destruction or redistribution; send them to DRMO; or advertize
them to other units for use other than originally intended. If
shipment is determined to be too costly, Medlog is left with
the burden of disposal.
Medlog' s ability to manage mobilization quantities of
pharmaceuticals needs to be addressed. The current system of
forecasting expiration dates by lot number is a tremendous
undertaking. Once each pharmaceutical unit is placed into AMAL
blocks, the tracking system gets complicated. It requires
periodically opening blocks and inspecting each pharmaceutical
item by item. This requires extensive labor and paperwork and
is subject to error.
Medlog inventory costs consist primarily of carrying,
replenishment, and disposal costs. Carrying costs are incurred
by AMAL storage requirements, costs of pharmaceuticals, and
expenses incurred for expiring drugs. Replenishment costs are
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incurred for routine replacement and priority, unanticipated
requisitions. Personnel costs, while important, are funded
from different appropriations: Military Pay, Navy and Marine
Corps (MPN, MPMC)
.
The current system can be summarized as follows:
1
.
Personnel visually inspect each item for quantity,
expiration and condition.
2 Personnel locate each item on an ALR and picking
ticket, then annotate any adjustments i.e., lot number,
quantity, and expiration.
3. Forms are sent to the Data section for key data entry
adjustments to the Medlog Class VIII Requirements Database.
Replenishments are ordered to fill shortages, and FDA
extension requests are initiated.
4. Finally, picking tickets go to the Bulk warehouse for
replenishment and/or procurement if the item is not-in-stock
(NIS) . Items to be removed from bulk are subtracted from the
inventory list. Medlog does not have a reorder point (ROP) or
safety stock policy.
5 Expired or expiring drugs are removed and placed
outside storage blocks awaiting disposition.
One advantage of the current system is the manual process
itself. It is easy to perform and does not require special
training. Opening and inspecting AMAL blocks for required
stocks is physical work which ensures no idle time. The
inventory process maintains constant checks, which are
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essential to the proper security for all assets. Another
strength of the system is the organizational structure. The
structure has well established lines of authority and
communication. Medlog objectives are constantly incorporated
in the daily taskings . They have SOPs for every specific
tasks, including issue and receiving, requisitioning, and
receipt control. Decisions are made based on reports, such as
the PWR Asset Requirements report which determines excesses
and shortages by NSN. To avoid interruption of supply, only
total current assets on the reports plus substitute items and
FDA shelf-life extension nominations are considered good
assets. The forecast report is a good tool to project
expiration dates for the succeeding 12-18 months. Items with
less than 12 months shelf-life are retained for
redistribution. Requisitions are coordinated through SASSY.
Another strength of Medlog' s management structure is the
voluminous guidance by various Marine Corps Orders, Naval
Instructions and SOPs. Procedures are incorporated in all the
training plans. Inventories are conducted on a periodic cycle
and during pre- and post-deployment training. All bulk shelf-
life items are stored in a separate and distinct area. The
Medlog has established a supply management program to train
personnel to perform their duties.
On the other hand, the system has problems and weaknesses,
as evidenced by the error rate in inventories. Despite quality
controls in maintaining PWR pharmaceuticals, Medlog spends
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long manhours in taking inventories and still has $2.0 million
worth of pharmaceuticals waiting to be extended, replaced or
disposed of. This is due to the different lengths of potency
and packing requirements of pharmaceuticals. The FDA is the
only agency for the Navy for expiration date extension
testing. Considering the lead time for testing, typically 270
to 365 days (T. Brown 1989), the FDA shelf-life extension
program is of little help to Medlog. Furthermore, FDA is
currently faced with problems of underfunding and impending
management instability (Benac, 1991) . The DoD needs to
establish its own centralized program to improve the stability
of those PWR pharmaceuticals that are stockpiled.
B. MANAGEMENT AND PROCUREMENT GUIDANCE
This section discusses the FDA shelf-life extension
program and the general process by which pharmaceuticals are
ordered.
1 . FDA Shelf-Life Extension Program
The FDA Shelf-Life Extension Program was initiated by
Commander, Naval Medical Command, now Bureau of Medicine and
Surgery (BUMED) , in conjunction with the FDA. This program
retests certain pharmaceuticals to determine the feasibility
of extending the shelf-life. Prior to August 1986, all expired
pharmaceuticals would automatically be sent to the Disposal
section. Pharmaceuticals within six months of expiration were
advertized to MTFs for redistribution before being sent to
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Disposal to await their expiration date (Medlog Shelf-life
SOP, 1987) . The Shelf-Life Extension Program potentially saves
the government millions of dollars annually.
The SOP at Medlog directs that pharmaceuticals meeting
requirements are nominated for potency testing every three to
six months. Requirements are set by NAVMEDLOGCOM. The Defense
Medical Standardization Board (DMSB) designates criteria for
extension and identifies certain military unique dated
material which may be considered for extension. Appendix C
lists unique medical items that may be considered. Medlog
verifies expiration dates, lot number, and quantity on hand
for each item nominated. The Data section maintains a program
to list all pharmaceuticals within 18 months of expiration
which have a value of at least $5,000 per lot. Samples of
pharmaceuticals by lot are packaged and shipped to FDA and
items are placed in a suspension status. Once approved and
extended, pharmaceuticals are relabeled for new extension. The
program conducts laboratory testing on sample lots for PWR
pharmaceuticals. If testing demonstrates that a lot is safe,
and will remain safe for a determinable period, shelf-life
extension is approved. Although the suspended assets are
considered good assets, they will necessitate immediate
replenishment if the request is disapproved.
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2 . Procurement Guidance
The DPSC conducts central inventory management and
procurement for standardized medical supply for all the DoD
services . External from DPSC is DMSB which consists of tri-
service medical experts responsible for technical review and
approval of medical items. DPSC, DMSB, FDA and the service
field medical officers work closely to decide what
pharmaceuticals will be standardized (Petroski, 1987)
.
The services submit requisitions to DPSC, which in
turn immediately ships pharmaceuticals to the customer.
Medical materials are stored in CONUS DLA depots. DPSC
practices a first-in-first-out (FIFO) shipping policy (T.
Brown, 198 9) . DPSC ensures that pharmaceuticals shipped to
customer have at least 12 months of shelf—life remaining. This
may pose problems when received by lower echelons such as
Medlog
.
C. ANALYSIS OF PROPOSED ALTERNATIVES
1
. Drug Stability Studies
The Pharmaceutical field has conducted in-depth
investigations on the stability of drugs. Of particular
interest to logisticians is the formulation and production
processes, the role of the container and the effect of storage
and distribution of packaged pharmaceuticals on their
stability or potency. A review conducted by Mollica, Ahuja,
and Cohen (1978) identified the many factors affecting
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stability and outlined what a stability program should
include. They recognized the economic and competitive reasons
for monitoring drug stability.
The subject of stability evaluation is a very broad
and extensive process and is beyond the scope of this thesis.
However, a description of the topic could provide an
understanding of the process and how it relates to storage,
expiration dates and packaging pharmaceuticals. The
disciplines primarily involved with stability are
pharmaceutical analysis and product development. However,
physical and organic chemistry, mathematics, physics,
microbiology, toxicology, production, packaging, engineering,
quality control, and distribution are all included (Mollica
et.al. , 1978)
.
Results of stability evaluations are obtained from
methods based on solvent extraction, gas chromatography and
mass spectrometry to determine the level of degradation.
Analysts are required to have knowledge of the physicochemical
properties of a drug, degradation products, degradation
mechanisms, and degradation reaction rates to perform
stability evaluations. Studies on drug stability and
temperature exposure show a direct relationship. Identical
sets of drugs are usually compared to analyze the effects of
exposure to light and heat. One sample is subjected to
environmental conditions while the other is kept under a
controlled environment and used as a reference sample. Drugs
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subject to temperature as high as 40 degrees centigrade can
degrade to the point where patients will not respond to normal
drug doses (Valenzuela et . al . , 1989) . Newton and Miller (1987)
stated that for every 10 degrees centigrade increase in
temperature, chemical reaction rates increase twofold, which
cause drug degradation. The stability evaluation also
determines effects of environmental conditions on the product.
Other factors commonly tested include humidity, light and air.
They accelerate, catalyze, or mediate hydrolytic (addition of
water)
,
photolytic (action of light) and oxidative
(combination with oxygen) reactions.
Extrinsic to the stabilization of the drug form is the
stability of the drug-container combination. The container is
an integral part of the pharmaceutical, as with topicals and
injectibles. A specific study on the effect of containers on
stability is shown in Appendix D. Additional studies in the
choice of container are necessary to obtain total drug
stability. Pharmaceutical packages are designed to provide not
only a means of transport and brand identification but to
serve more significant functions: to provide adequate
protection and to ensure the stability of the product while in
distribution and storage.
All of the above factors and packing conditions form
the basis for shelf-life determination. Expiration dates have
a real significance under specific storage conditions. DPSC
has an "Accelerated Aging Test" program to determine the
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stability of a pharmaceutical under anticipated storage
conditions in the field, assuming limited exposure to stress
conditions. The objective of stability testing is to determine
the time period and conditions for which the product is
satisfactory. The expiration date limits the time during which
the drug may be used, provided it is stored under the
prescribed storage conditions.
Once results of the studies are obtained, they must be
validated by the drug stability program, as pointed out by
Trissel and Flora (1988) . Validation is an essential step in
the analytical process. The stability-enhancing results of the
analysis must be verified.
Expiration dating is the ultimate practical result of
determining stability. Short shelf-life generates wastage and
high disposal costs. Stability is the inverse of degradation.
All materials undergo degradation at a rate defined by
chemistry and physics. The basic technique to measure the
degradation rate at different environmental conditions is to
extrapolate to the anticipated storage temperature and convert
this extrapolated rate constant into months of shelf-life
(Zakowski, 1991) .
The drug stability processes described above could be
centrally managed by the government to standardize the shelf-
life methodology for military unique as well as generic combat
support. A network between laboratories, drug industry, and
the government could be established to address the issue of
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shelf-life on DoD pharmaceuticals, including those
prepositioned with the combat units.
2 . Bar Coding for a Transactional Inventory Review
The inventory practice Medlog employs may not be the
most effective process. Manually checking for expired drugs is
subject to errors, in both tracking quantities and in
generating timely requests for replenishment and extension.
The use of a bar code system may provide timely replenishment
decisions, decrease time and labor resources, and provide
effective decisions in redistribution and disposal.
Chester and Zilz (1989) describe a bar code as a
specific arrangement of rectangular bars and spaces that
represent data characters (letters, numbers, and symbols) . The
code is read by a light source (scanner) which generates an
electrical signal. The signal is translated by a terminal
(also known as bar-code reader, device, or transaction
manager) to a usable form. Bar code technology has enhanced
labor efficiency through time savings and increased record
accuracy (Chester and Zilz, 1989)
.
Since one of DoD's objectives is to reduce manpower,
implementing bar code technology is a means to achieve this
objective. Bar codes for PWR pharmaceuticals can be added to
the packages and to the AMAL blocks. Bar codes will provide
up-to-date data, such as expiration dates, for an automated
database with a high degree of accuracy. Medlog can use bar
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codes to track drug expiration data, monitor inventories,
control narcotics and coordinate replenishment . It could
replace the item by item counting by inventory teams.
Standardized bar coding within the health care
industry is accomplished through the Health Industry Bar Code
Council (HIBCC) . The HIBCC develops and publishes standards
for implementing bar codes in health care and provides labeler
identification codes to manufacturers, distributors, and
customers. They also disseminate information on bar codes to
the above users as well as to manufacturers for bar code
software and hardware and health care providers (McGee, 1989)
.
The implementation of a bar code system can serve as
a local solution to the shelf-life inventory management
problem at Medlog. This system is to be built around automated
data-collection technology. Bar code labels and scanners
provide an accurate, fast way of data entry for data
management
. The system can save personnel time in recording
ALRs
. Manually, this is a cumbersome and unreliable task. Bar
code systems have typically had an investment payback period
of 12 to 18 months (Betts, 1991)
.
The system can improve the accuracy and timeliness of
the inventory data. It can track the expiration dates of each
drug and flag those that need to be FDA extended or disposed
of. Drugs that require disposition could be redistributed in
a more timely manner for use by other government agencies . Bar
coding improves data accuracy by a factor of 10,000. According
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to Betts, where manual data entry has one error per 300
entries, bar code scanners have an error rate of one in every
three million entries.
The use of bar codes is consistent with the
transactional review method of inventories that suggest having
a real-time inventory tracking capability. The system would
eliminate the need for key-driven data entry. This is known as
source data automation and will reduce if not totally
eliminate the existence of input errors. Inventory personnel
need only pass bar code labels of the drug items over a laser
scanner and information is updated. For bulk items, portable
data entry devices, such as hand-held wand scanners, expedite
data input at the point of origin. The wand scanner also reads
package labels for shipping and receiving. The Contingency and
Deployable Units sections, who are tasked with counting blocks
of AMAL, could use a scanner to read labels on the blocks.
D. SUMMARY
The current inventory practices at Medlog involve physical
counts and checks of AMAL blocks. This review monitors the
expiration of pharmaceuticals. Pharmaceuticals are extended by
reguests or by extension notices from the Navy Medical and
Dental Materiel Bulletin. Non-extendible and expired drugs are
redistributed and disposed of respectively. The periodic
review causes error and expired item rates higher than the
industry average or acceptable levels. A drug stability
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program and a transactional method of tracking inventory could
help solve the problem. The proposed alternatives present
viable solutions to institute bar coding technology to assist
Medlog managers in making accurate inventory decisions. The
benefits of increased shelf-life and accuracy allow Medlog to
carry out its mission more effectively.
The next chapter discusses tradeoffs and cost-benefit
analysis of proposed alternatives. A summary of the issues
proposed by the recommendations will be presented and other
qualitative benefits.
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IV. DISCUSSION AND ANALYSIS
The current Medlog inventory practices and. shelf-life
management were presented in Chapter III. Alternative
management tools, drug stability program and bar coding for
inventory management, were suggested to show how the present
process may be improved. The level of readiness will
definitely increase with a stability program and a fully
automated on—site inventory tool to manage pharmaceuticals.
This chapter will discuss further details on Medlog
pharmaceutical inventory policies and the applications of
alternative management methods.
A. CENTRALIZED DRUG STABILITY PROGRAM
1 . Cost-Benefit Analysis
A DoD stability program for PWR pharmaceuticals helps
to solve the shelf-life problem. Physicochemical properties of
drugs may be the focus of programs to develop packages for
military unique items. Issues that the program could address
are selection of containers, package stability, storage
requirements, expiration dating and regulatory considerations.
The cost of the shelf-life improvement program is traded-off
with inventory, replenishment and disposal costs. With a
longer shelf-life, manpower needed for periodic inventories
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can be diverted to other peacetime training while readiness
for medical support is maintained.
The types of pharmaceuticals required by peacetime
MTFs and those place in AMALs are different. For example,
atropine may be required in large amounts in a possible
chemical warfare. The drug is used to counteract chemical
agents anticipated on the battlefield. Studies described by
various researchers show that temperature is a major
contributing factor to the instability of atropine sulfate.
The stability program may help predict the optimal temperature
for storage. Cost-benefit analyses can be used to justify
whether to invest in capital to prolong storage life.
A centralized stability program within the DoD will
require initial outlays for facilities and equipment . In
addition, research and development (R & D) increases start-up
costs . Investment in the short run is costly but potential
benefits may outweigh the costs in the long run. The problem
with PWR pharmaceuticals is the short shelf-life which results
in high annual replacement cost to maintain readiness. To
demonstrate the potential savings, it is assumed that a 10%
increase in shelf-life will save Medlog approximately 10% of
operating costs, as shown in Figure IV-A-1 . Increasing the
shelf-life by 33 1/3% and 50% yield similar potential savings.
Based on stability studies, ultra low refrigeration may be
sufficient to increase shelf-life by 10%. Refrigeration units
cost $30,000 each. One refrigeration unit is needed per 150
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NSNs of consumables or pharmaceuticals, as described in Figure
IV-D . Thus, Medlog would require nine units. The total start-
up cost for a 10% shelf-life extension using refrigeration is
$270, 000.
Figure IV-A-1 shows the annual savings in disposal,
replenishment and inventory costs as shelf-lives are extended
by different amounts. An increase of 10% will provide annual
savings of $249,189. Based on an average shelf-life of three
years, the new shelf-life is 3 . 3 years. As shown in Figure IV-
A-2, the net present value (NPV) of the savings over a five-
year period is $944,625 at a discount rate of 10%. Deducting




Cost Savings 10% 33 1/3% 50%
Disposal 29,533 98,346 147,666
Replenishment 200,000 666,000 1,000,000
Inventory 19,656 65,454 98,280
Total $249,189 $829,800 $1,245,946
Note: Potential savings are based on operating costs
provided in Figures IV-B and IV-C
.
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Figure IV-A-2 Cost Flow Diagram
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$674,625. Increasing the shelf-life by 33 1/3% or more may-
provide even greater net discounted benefits
.
Investment in stability methods to increase shelf-
life, as shown in Figure IV-A-3, looks attractive for DoD
.
Increasing shelf-life by 10% may only require temperature
control methods. Increasing shelf-life to 33 1/3% may require
both temperature control and R&D into packaging and other
physicochemical properties of drugs. From Figure IV-A-3, the
potential annual savings for a 33 1/3% shelf-life extension is
$829,800. Over five years, the discounted total savings is
$3,145,606. Thus, the marginal net savings as shelf-life is
extended from 10% to 33 1/3% is $2,200,981. Total additional
R&D costs to extend shelf-life from 10% to 33 1/3% should
not exceed this incremental savings. If it costs $270,000 to
extend shelf-life by 10%, then the total R&D costs to extend
shelf-life to 33 1/3% should not exceed $2,470,981.
Extending shelf-life to 50% will require additional R
& D, possibly into additives and other drug forms. From Figure
IV-A-3, the total potential annual savings from a 50% shelf-
life extension is $1,245,946. The total discounted five-year
savings are $4,723,132. This represent an increase of
$1,577,526 over the 33 1/3% shelf-life extension. Thus, the
incremental R&D costs to increase shelf-life from 33 1/3% to
50% should not exceed $1,577,526.
To determine the optimal shelf-life extension program,
the incremental R&D costs to increase shelf-life is
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compared with the incremental discounted savings . As the
incremental net savings exceed the incremental R&D costs,
DoD may continue to extend the shelf-life. As the shelf-life
is extended, the R&D costs to obtain further extensions are
likely to increase. When the incremental R&D costs exceed




Shelf-Life Annual Discounted Marginal R&D
% Increase Benefits Benefits Benefits Parameters





33 1/3% 829,800 3,145,606 2,200,981 Drug
Packaging
50% 1,245,946 4,723,132 1,577,526 Additives
and Drug
Form
33 1/3% R&D Not-to-exceed (NTE) $2,470,981
Figure IV-A-3 Marginal Benefit - Marginal Cost Analysis
The cost analysis and tradeoff described in Figures
IV-A-1 through IV-A-3 provide a model for demonstrating
potential benefits of a stability program. To determine the
actual start-up cost of a drug stability program (i.e., R&D
and equipment) would require a more intensive life-cycle




2 . Benefits of a Drug Stability Program
There are cost tradeoffs between the factors
contributing to shelf-life extensions. A decrease in storage
temperature increases refrigeration costs. However, with
longer drug shelf-life, disposal and replenishment costs
decrease. Another benefit of a drug stability program is
determining the best drug form for stockpiling. Powdered
antibiotic products often expire several years after their
production. However, once the pharmaceutical is reconstituted
in a diluent, the rate of degradation increases dramatically
(Newton and Miller, 1987) .
A drug stability program under DoD control decreases
the lead time for extension requests since retesting will be
conducted within the agency. The program also invests in
research and development to enhance the sterility and potency
of pharmaceuticals. This is conducted through stability
evaluations described in Chapter III. Initial outlays for
special storage equipment and packaging materials will
outweigh the costs in the long run. An increase of the shelf-
life by 10% shows potential savings in operating costs i.e.,
disposal, replenishment and inventory. Equally important is
the effectiveness of Medlog in terms of readiness.
The program also conducts special studies in new
methods of maintaining pharmaceuticals. An example is the use
of reconstituted or unreconstituted drugs. While the use of
pre-mixed forms results in efficiency for MTFs in peacetime,
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the ready to use form is not appropriate for PWR
pharmaceuticals. If there is a high demand for the drug, pre-
mixed doses could be cost effective for MTFs, because
technicians can devote more time to other labor intensive
pharmaceutical duties . However, in the case of stockpiling
pharmaceuticals, it is best to store them in their most stable
form and reconstitute them only prior to mobilization or
training exercises. Stockpiling pharmaceuticals in the most
stable form (unreconstituted) , with the appropriate container
(glass with minimal air content) , and the proper storage
environment leads to longer expiration dating and personnel
time savings, which translates to less inventory and disposal
costs
.
In case of a mobilization or training exercise,
reconstitution may either be done by batch method (advanced
preparation) or by extemporaneous method (prepared at the
field on a daily basis) . Part of training could be the amount
of time and labor involved in reconstitution of
pharmaceuticals in the field. To determine the preferred field
method would involve time-and-motion studies. Reconstitution
includes time to retrieve and assemble materials, prepare lot
number/expiration date labels, and repackage prepared doses
for the field.
In summary, investing in a drug stability program
would increase costs in research, packaging, drug forms, and
storage facilities (temperature and humidity control
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equipment) . The benefits would include longer shelf-life,
decrease in ordering and disposal costs, increased readiness,
and reduced labor costs
.
B. MEDLOG BAR CODE APPLICATION
1 . Tradeoff Studies and Cost-Benefit Analysis
Medlog can be characterized as having a labor
intensive inventory system. There are huge inventories of
drugs expiring annually and awaiting disposition. In addition,
inventory records on expired drugs are inaccurate and there
are deficient quantities in AMALs (surpluses or shortages)
.
Experience in the food industry indicates that today'
s
grocery stores, retail and manufacturing industries have used
bar codes as a critical part of inventory management. The
health care industry is now starting to use the bar code
system to improve health management systems . In light of DoD
attempts to reduce funds and decrease manpower requirements,
a bar code system could help alleviate Medlog' s shelf-life
problems. Investment in a flexible, automated field system
could provide a solution to pharmaceuticals in the AMAL
stockpile
.
The need to seek an alternative inventory review to
provide the required medical readiness for the MEF is a
strategic issue in view of the plans to downsize DoD. This
section provides a cost-benefit analysis and tradeoff study of
a bar code system to provide a transactional inventory
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control. Costs associated with acquisition, installation,
training, and maintenance are explored. The estimated costs
and benefits are traded-off to provide a breakeven analysis
for recoupment of the capital investment
.
The proposed system is evaluated for a five-year
period. The five-year period is used for analysis to exemplify
the average useful life of bar code technology. It is usually
the period which computer hardware and software changes occur.
The bar code system is analyzed in terms of cost savings and
benefits from increased accuracy, decreased time and labor
resources (includes disposal), and improved redistribution.
The increased accuracy is a result of information stored from
scanned codes vice manual counting and shelf-life
verification. Concerns over inaccuracies and deficiencies
mandates audits and review analyses similar to the
investigation conducted by Field Supply Office Two. As
described below, Figures IV-B through IV-F provide the cost
analysis of the proposed system. The figures are based on
realistic assumptions using available data and are provided
for demonstration purposes only. Calculations are presented
with the figures. Appendix E provides additional cost data.
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COST DATA
(Computations are based on Annual Cost Structure)
Medlog Data
Annual Inventory
Number of line items
Operating Costs
Replenishment Costs






















2% or $43,152 (Expiration
dated items)
Industry Data on Bar Code System
Payback Time




12 to 18 months
1 per 3,000,000 entries*
90 minutes per trainee at
$200-250/hour
1% of Total Annual Costs
1-2 hours per day per
technician
'Manual Data Error Rate 1 per 300 entries
Oakland Naval Hospital










Figure IV-E Cost Analysis Extrapolation
44
INVENTORY TEAMS
Total Personnel: 39 (USN & USMC)
Composition: E2-9, E3-16, E4-11, E5-2, E6-1
Total Annual Personnel Costs based on Base Pay, BAQ
(Partial and BAS from FY91 pay chart without dependent)
= $546,151
Time Required to Inventory (periodic)
a. Hours per day: 8
b. No. of days: 90
Annual Cost t 250- t 8 = Cost per hour
546,151 t- 250 -r 8 = $273.00
No. of hours to inventory X cost/hr = Inventory Labor Costs
90 days X 8 hours X $273.00 = $196,560
No. of hours saved X Cost per hour X No. of Days to
Inventory = Annual Savings
2 X $273.00 X 90 = $49,140 (savings)
Note: The inventory cost per hour is calculated using total
annual personnel costs divided by 250 work days in a
year and by eight work hours in a day.
Figure IV-C Inventory Labor Cost Calculation
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Cost Unit Cost Estimate
$2,415 9* $21,735 $25, 160
$1,099 9 $ 9,891 $11,450
$6,000 $ 6,000 $ 6,945
$ 193 $ 193 $ 224
$22, 057
$ 200 12 $ 3, 600 $ 3,600
per/hr
$69,436
Operating Costs $l,500/yr (average)
Maintenance Costs $4,738/yr (10% of Total System
Requirements excluding
installation and software)
* Number of units needed to inventory 40 % of total line
items
. Based on Oakland Naval Hospital Central Processing
Dept . which uses 1 scanner per 150 NSNs : 40% of 3318 =
1327; 1327 -f 150 = 8.8 « 9 units.
Figure IV-D Bar Code System Cost Data
Source: Naval Hospital Oakland Materials
Management
Date acquired: 1988
Inflation Rate Used: 5%
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1,476, 665 1,461, 900 +14,765






Five-year total 2,243,705 1,975,986 +267,719
1. 196,560 (Fiq. IV-C) X 5 = 982,800; 49,140 X 5 = 245,700
(savinqs)
2. 295,332 X 5 = 1,476,665 (Bar Code System is assumed to save
1% of disposal cost: 1% savinqs = $14,765)
3. 43,152 (Fiq. IV-B) X 5 = 215,760/ 21,576 X 5 = 107,880
(savinqs)
4. 6,238 X 5 = 31, 190
Figure IV-F Tradeoff Study Over Five Years
(Undiscounted Costs)
The averaqe annual inventory of Medloq totals
$23,973,704. Other cost data are presented in Fiqures IV-B and
IV-C. Operatinq costs, not includinq personnel pay, are funded
under Operations and Maintenance, Marine Corps (O&M, MC) .
Fiqure IV-B lists operatinq costs and bar code savinqs data.
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Figure IV—C shows the composition of Medlog' s inventory team
and a calculation of the inventory costs used in the analysis .
A periodic review is assumed to require 90 days for inventory.
Total system cost is presented in Figure IV-D . The total
system requirement is $69,436. Operating costs were estimated
from the average cost incurred by the Central Processing
Department at Naval Hospital Oakland. Maintenance cost is 10%
of system requirements excluding installation and software.
The cost effectiveness measures the cost savings which the bar
code system could provide. From industry data, bar code use
indicates a 1% savings on total annual costs excluding capital
investment (Krause, 1991) . For our discussion, it is assumed
that industry results represent a good measure of the overall
savings for Medlog. In the analysis, savings are based on the
percentage of average inventory, replenishment cost, disposal
cost, and redistribution savings. Calculations are presented
as footnotes in the figures. For all calculations, it is
assumed that total yearly costs for the five-year outlay are
constant and are affected by inflation. The discount factor
used is 10%. The overall discounted net savings is $186,148
for five years, as shown in Figure IV-E . The total annual
potential savings from labor, disposal and redistribution is
$73,669. The NPV of the total potential savings after five
years is $279,228. Capital investment costs $69,436. Adding
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annual operations and maintenance costs of $6,238 yields a
total NPV cost of $93,080. The difference in NPV values
provides the overall net savings. The payback period is 1.03
years. In Figure IV-F, the tradeoff study indicates that the
total expected (undiscounted) savings from the bar code system
is $267,719 for five years. The analysis quantifies the
potential benefits of a bar code system investment. Figure IV-
F shows that the total benefit is greater than the total cost
in the period compared.
The use of bar codes initially has capital and start-
up costs, but the benefits will outweigh the costs. The
benefits include improved expiration tracking, reduced
inventory time (which may justify personnel reduction) , and
better decision-making in redistribution and replenishment.
Managers can better make decisions as to ordering frequency,
reducing stockouts, and making timely FDA extension requests.
The level of combat support readiness may be jeopardized by
the inaccurate inventory of pharmaceuticals under the periodic
review. As the required PWR pharmaceuticals are correctly
managed, Medlog' s combat support readiness is maintained.
2 . Sensitivity Analysis
The effectiveness of the system is based on the
savings provided by increased accuracy in tracking. Therefore,
timely decisions are made as to extension requests,
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redistribution, replenishment and disposal. The analysis shown
in Figure IV-E used a discount rate of 10% and accuracy-
savings of 1%. It showed a NPV of $186,148 for five years.
Four sensitivity analyses provided in Figure IV-G illustrate
the robustness of the bar code investment . The analyses use
discount rates of 12% and 8%, respectively, and potential
savings of 2% and 5% from increased accuracy. These
percentages are not accuracy rates but the potential savings
from bar code inventory management. The sensitivity analyses
illustrate that the higher accuracy from bar codes results in
increased savings . The payback period is computed by dividing
the initial investment by the net annual savings from bar code
use .
Accuracy
Discount Rate Labor NPV Payback
Scenario Factor (Savinqs) Costs (Savinqs) (Years)
1 10% 1% Constant 186, 148 1.03
2 12% 1% Constant 173, 641 1.03
3 8% 1% Constant 199,787 1.03
4 10% 2% Constant 279, 128 .75
5 10% 5% Constant 558,090 .42
Figure IV-G Sensitivity Analysis
to Illustrate Robustness of the Bar Code System
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In conclusion, this section provides the costs
associated with the introduction of a bar code system for
Medlog. Monetary and quality benefits demonstrate the
attractiveness of investing in the system. Considering the
worst case scenario, the system can be expected to return its
original investment in 12-13 months. By investing in the
system, productivity and efficiency will improve . At the same
time, readiness increases as time spent in inventory is used
for training and other duties. Above all, the highest quality
of PWR pharmaceuticals in AMALs is maintained.
3 . Medlog Shelf-Life Management Model
The model being proposed for the PWR pharmaceuticals
inventory management is outlined in Figure IV-H . A drug
stability program is centrally coordinated by DPSC in
conjunction with the FDA, DMSB, DoD drug laboratories, and
drug manufacturers . Other key organizations are SASSY, Naval
Hospitals, and Naval Supply Centers or Depots. Once
pharmaceuticals are procured and received by Medlog, they are
labeled with bar codes prior to prepositioning to AMAL blocks
or storing them in the bulk warehouse. Required information is




























Redlstr l but Ion
*" Disposal
Figure IV-H Inventory Flow Model (Using Bar Code System)
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Pharmaceuticals placed in AMALs and in the bulk
warehouse are ensured of proper storage requirements . Items
placed in AMALs are scanned and data is stored into the Medlog
inventory database. On-line inquiries could determine the
shelf-life of pharmaceuticals and their location. Reports
could be generated to list all items within a certain period
of expiration for exception reporting. This will provide
timely extension requests and redistribution for non-
extendible items . A final step in the process is a Quality
Assurance program for the evaluation of the system. Results of
the review would then be compared to the manual system to
validate the cost analysis. The review process could also be
conducted in relation to the philosophy of Total Quality
Leadership (TQL) for continual improvement employing control
charts to ensure standards are maintained.
4 . Application
Based on the cost analysis presented in the preceding
sections, bar code technology provides monetary as well as
qualitative benefits. The system will eliminate item-by-item
entries on ALRs and picking tickets. Personnel still have to
determine items, quantities, AMAL composition and warehouse
location, but once these are set for AMAL blocks, bar code
labels are attached with all the required information.
Information on labels would include pharmaceutical name, lot
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number, expiration date, AMAL block, warehouse location or
bulk location. Personnel scan the label with a bar code
device
.
After inventory, the bar code reader is taken to the
Data section where it is attached to the Medlog computer.
Inventory data is electronically transferred to the database.
After the data is entered, exception reports may be produced
to identify item deficiencies and shelf-life forecasts. From
this, a picking ticket may be generated for Bulk and
Procurement to replenish expired pharmaceuticals. The
transactional inventory review permits continuous updating of
inventory balances when items are received and distributed to
the AMAL blocks. Furthermore, real time data provides better
planning for redistribution of non-extendible pharmaceuticals.
One requirement to consider is that bar code labels
must have a high resolution to compress multi-character bar
codes to a compact level. A high-volume laser printer could be
used. Such a printer can print up to 70 pages a minute and can
print continuously with few interruptions. The printout on
durable labels should be virtually indelible (Bar Code System,
P & IM Review, 1990) . The capability of a printer to produce
high resolution labels is essential in maintaining the
integrity of the labels, especially when the AMAL blocks are
deployed.
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5 . Benefits of a Bar Coding System
A return-on-investment analysis would follow a pilot
study to measure the ability to track all pharmaceuticals,
their expiration dates and proper disposition (i.e., extension
requests, redistribution, or disposal) . Equally important are
the time savings, increased shelf-life and maintained level of
readiness
.
The use of bar code data entry provides fast and
accurate collection of information in receipt control, AMAL
block assembly, bulk locations, replenishment and disposal of
pharmaceuticals. One of the obvious benefits of using bar code
entry and collection is the reduction by a factor of 10,000 of
the error rate from manual counting and keying in of
information. Adoption of bar code asset locator labels gathers
information instantly and accurately. The long hours of
detailed counting and ALR adjusting is reduced.
For every incoming item, receipt control generates a
bar coded label that channels items to AMALs and bulk storage
locations as appropriate. The NSN identifies the particular
drug being inventoried and will indicate required data. The
amount and volume of pharmaceuticals along with the need for




With bar codes, all information needed can be
extracted from AMAL labels that identify each drug. As the
bulk warehouse transfers items and releases them for AMALs,
bar code labeling identifies each item and feeds the data back
to the Medlog database. The system permits a number of
management reports. The reports could provide a detailed
analysis of total assets, locations, shortages, excesses and
expired items. The item placement report would help expose the
magnitude of any loss problem on a timely basis. Currently, it
is not possible to ascertain any loss until the next physical
inventory
.
In summary, these are computerized solutions that
incorporate bar code data collection techniques and allow
Medlog to provide assistance in complying with MCOs and
directives and increase the efficiency in maintaining
readiness. In addition, this technology will assist Medlog
planners in making decisions for redistribution of non-
extendible pharmaceuticals.
The cost-benefit analyses for the drug stability program
and bar code system have been conducted independently. The
total benefits of both proposals can not be determined by
adding the total from each individual programs. If both
programs are undertaken, the total benefits are likely to be
less than the sum of the individual programs. As inventory
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management improves with bar coding, savings from drug
stability may decrease, and vice versa. However, both
investments appear attractive enough that it is unlikely to
change the decision for either program.
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V. CONCLUSION AND RECOMMENDATION
A. CONCLUSION
Maintaining PWR pharmaceuticals is costly because critical
drugs are expensive, storage requires special conditions, and
stockpile necessitates continuous replacement due to limited
shelf-life. DoD should pursue a centralized Drug Stability
program to assist or relieve the FDA in extension studies
.
DPSC and the medical services through the centralized program
should further examine the possibility of increasing shelf-
life through research to improve packaging, formulate
stabilizers and use special containers for temperature
control . To encourage larger drug manufacturers to participate
in the program, DPSC should seek exemption from maximizing
competition when procuring PWR pharmaceuticals. It is the
large companies that generally conduct original research on
military unique items and can maintain the capacity to produce
low profit items
.
At Medlog, the bar code technology as described in
Chapters III and IV, provides financial and qualitative
inventory management benefits. The system reduces labor and
increases inventory accuracy. Bar coding can eliminate hours
worth of administrative work and almost all counting errors.
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Time savings can be reallocated to quality assurance
procedures and to peacetime training with the FMF units . This
overall analysis improves the operating efficiency of Medlog
and could be applied to the other Medlogs
.
B. RECOMMENDATIONS FOR IMPLEMENTATION
There are two possible ways to implement the bar code
technology. One is to obtain the expertise of an outside
integrator to convert all of the databases into bar codes . The
other is to handle the integration locally by requesting
conversion to bar coding from the MIS department of the local
command, such as Naval Hospital San Diego. At the
implementation phase, the following key points may aid in the
successful implementation of the system: (1) work flows, such
as procurement, receipt, AMAL placement, warehousing, and
disposition, must be well defined; (2) involve end users at
the start of the development process; and (3) lay out the
system for flexibility so that bar code formats, devices, and
printers can be easily connected for application. Information
systems people as well as people at the Supply Battalion
headquarters should be involved. The MIS and Data sections
should oversee the installation schedule and anticipate
problems before the system goes into full operation.
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Meyer (1991) presents a successful eight-step program in
approaching inventory accuracy. He states that people
management is the key to executing an inventory program such
as the bar code system.
First, managers must be aware of the problem and its
magnitude. The problem with Medlog is the high rate of
inventory discrepancies and the financial loss from shelf-
life expiration. Both factors equate to a decreased
support readiness.
Second, the key decision makers must get involved.
Third, a review of how and what must be done should be
documented. The SOPs must be reviewed and updated to show
a step-by-step process with the expected outcomes
described. Additionally, the SOPs should be simple enough
for inventory teams to follow.
Fourth, goals and control procedures must be communicated
to personnel concerned. Training is essential since
inventory accuracy starts with the workers.
Fifth, a test area or pilot area should be established
consisting of a number of AMAL locations to introduce the
system. The test area is necessary to identify strengths
and weaknesses of the system to correct problem areas
and/or reinforce training. Beginning with a test area
should help to minimize the pain involved in learning from
mistakes
.
Sixth, once the system is proven effective, integrate the
rest of the Medlog inventory.
Seventh, once the system is implemented, quality controls
should be employed to assure the system is performing as
expected and to identify areas for improvement.
Lastly, supply audits, such as the one performed by Field
Analysis Supply Office Two should continue to promote
efficiency.
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Bar coding may also be implemented using the cutover
method (Ferravanti, 1990) . Inventory teams perform the task in
parallel. The teams simultaneously enter data using the
current system as well as the bar code system until they are
convinced of the accuracy provided by the replacement system.
The advantage of running in parallel is security against major
failure in the new system.
Another approach is the data process design methodology.
An example is the traditional life cycle approach as described
in Chapter IV. The sequence is as follows: systems
requirements are defined; output and input formats are
designed; from these formats the system'' s internal processing
is defined; the system is coded and tested; procedures are
written; the users are trained and finally data is converted
as the bar code system is brought on-line (Ferravanti, 1990) .
The successful implementation of the system also requires a
champion as the motivating force or leader. Top management as
well as operational personnel must be committed in keeping the
project at a high level of visibility during the entire
implementation phase.
C. CAVEATS TO IMPLEMENTATION
1. Data overload is a potential drawback to detailed and
timely information. Medlog has to enlist MIS support to make
62
best use of the huge amount of data that bar code technology
can obtain. To avoid information paralysis, the Data section
must establish specific guidelines about the structure of
reports and how data should be placed in AMAL blocks to be
analyzed. The reports must also conform to the requirements
mandated by MCOs and BUMED instructions.
2. User anxiety is a possible barrier to implementation.
There is oftentimes a "resistance to change" reaction of users
at the start . They have to invest time in training and have to
accept the change in procedures they are accustomed to . In the
face of impending change, personnel may become nervous and
anxious . They may worry about the ability to meet new demands
and expectations . The commanders will have to manage the
resistance through training, communication and facilitation by
introducing the new system gradually. Although it may be
different for the Marines having a strong military discipline.
3
.
Top management could be a barrier to the proposed
system, especially if there are different conflicting
priorities for the FMF structure. Even middle management
sometimes views proposed solutions as just another
bureaucratic administrative reaction to a management problem.
A proposal could be buried in a in-basket or may end up in the
shelf to collect dust. This attitude prevails because
sometimes the status quo is preferred to change. The job of
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middle managers is to convince key decision makers that a
shift of capital investment through Other Procurement Navy
(OPN) funds today would save annual Operations and
Maintenance, Navy or Marine Corps (0&M,N and 0&M,MC) funds in
the outyears
.
D. RECOMMENDATIONS FOR FURTHER STUDY
1. A pilot study should be conducted at Medlog to further
determine the feasibility of bar code technology. Integration
of the system could either be performed by in-house
information systems personnel or by outside consultants,
usually a vendor. A complete comparison can then be conducted
between the manual process and the bar code system. The
sequence from initial AMAL placement until replenishment can
be compared across the two methods to determine differences in
time and errors from actual data.
2. The Defense Priorities and Allocation System (DPAS)
helps to keep current national defense programs on schedule
and provides an operating system that can be expanded in a
national emergency. Using this system, pharmaceuticals of
certain designated war supplies may be included in the Federal
Central Management (FEMA) . Special instructions for normal
peacetime requirements could be maintained with an operating
mechanism that can be expanded during national emergency. A
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segment of DPAS is the Special Priorities Assistance which
allows the services to expedite deliveries, place priority
rated orders, locate suppliers, and to coordinate information
between customers and vendors. In Medlog, the flow of
pharmaceuticals could be coordinated as follows: FEMA and DPSC
establish policies with the drug industry using the DPAS
concept of rated orders for D-day significant PWR
pharmaceuticals; pharmaceuticals are delivered to Medlog where
they are assembled into AMAL blocks as indicated by the AMAL
using ALRs; assembled AMALs are distributed to FMF units for
deployment and usage for D+60 days until normal replenishment
is maintained. DPSC, DMSB, and FEMA should coordinate
mobilization and national emergency planning for
pharmaceuticals
.
3. Currently, most bar code users use the hard-wired data
collection method. The added task of relocating data
collection devices and readers for tracking inventory still
adds considerable time. There are now bar code producers who
offer wireless data collection for real time transactions.
This would provide more flexibility to easily move bar code
collection points anywhere in the warehouse or even out in the
field (FMF training deployments) . Wireless data collection
saves wiring costs and increases productivity by eliminating
cables for hard-wired readers.
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4. Lastly, the consolidation of Medlog assets from the
three MEFs could be stored in a single location. There is a
tradeoff between inventory costs and transportation costs.
Other factors to consider include facility location, operating
costs that include overhead, manpower costs, material handling
costs, and mobilization. If we consolidate all assets into a
single warehouse, benefits could include lower overhead and
inventory. The disadvantage would be the lead time to mobilize
and added costs of transportation. With the geopolitical arena
perceived as decreasing in threat, perhaps consolidation would
help justify budget reductions and manpower downsizing.
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APPENDIX A
Current Authorized Medical/Dental Allowance List
FMF AMAL/ADALs are arranged in a modular concept. The
equipment module contains equipment and reusable material
required to establish the basic function of the module (e.g.,
AMAL 63 9 - Operating Room Equipment) . The supply module
contains consumable material designed to support the function
in the treatment of a designated number of casualties or to
perform a specific task. For readiness purposes, an equipment
module may be stored in combination with its corresponding
supply module. The material listed in each AMAL/ADAL is the
minimum amount to be maintained. For a complete description
of each AMAL/ADAL, refer to FMFM 4-50, Health Service Support,
MCO6700.2D dated 2 January 1991. It is the current primary
source for the policies and procedures for procurement of
AMAL/ADALs to meet the required capability of the FMF. The
MEF consumables, which include pharmaceuticals, are listed
below. The supply quantity held by Medlog is equal to the
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- Headquarters and Service Company
- Surgical Support Company
- Collecting and Clearing Company
- Table of Organization
Source: FMFM 4-50 Health Service Support Manual
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APPENDIX B























Globulin Immune USP 6505-00-153-8278
Aspirin Tablets 6505-00-153-8750
Bacitracin Ointment 6505-00-159-6625



























Albumin, Normal Human Serum
Atropine Sulfate Injection
Sodium Chloride - Sodium Bicarbonate Mixture
Kaolin and Pectin Mixture, Dehydrated
Chloroquine and Primaquine Phosphates Tablets





Mean anhydrous morphine content of kaolin and morphine
mixture BP when stored in different containers of different
sizes and materials.
Time 3 mos 6 mos 12 mos 24 mos
Container Type (mfq . date) Storage Storage Storage Storage
a. 100 ml of mixture .0071 .0071 .0071 .0070 .0067




b. 100 ml of mixture .0071 .0071 .0071 .0067 .0064
into a 100 ml white
flint glass, sloping •
shoulder, medicinal
flat
c. 2000 ml of .0071 .0071 .0070 .0065 .0062
mixture into a two
liter amber glass
Winchester
d. 2000 ml of .0071 .0068 .0066 .0059 .0051











Proposed limits: 0.0061 - 0.0078% w/v
71
Discussion: All containers were stored undisturbed in
normal light conditions at ambient temperatures. Results
showed that a time related oxidative degradation of morphine
is dependent upon the volume-fill of the container. Well-
filled containers demonstrated virtually no loss of morphine
over a six-month period. The morphine content demonstrated a
much lower rate of degradation when stored in glass than when
stored in high density polyethylene. The difference in rate
of morphine degradation between two amber glass containers can
be explained in terms of headspace air above the level of
mixture. The study concluded that the shelf-life of kaolin




and Jennings, P., "Kaolin and morphine
mixture BP : effects of containers on the stability of
morphine," The Pharmaceutical Journal
, p. 682, June 2, 1984.
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APPENDIX E
Cost Data Sources and Computations
1. Class VIII PWR Asset Requirements Report (16 July 1991)
Operating costs/yr: $2.5 mil (excludes personnel cost)
Replenishment costs/yr: $2.0 mil
Consumables: 40% of Total Assets
1.00% MEF Requirement Avg . Inventory: $23,973,704
Excess/Overstock: $2,094,836 (8.7%)
Equal Requirements: $1,265,255 (5.3%)
Shortages: $11,247,118 (46.9%)
Number of line items: 3318 NSNs
2. Supply Analysis Report - 21012
Disposal Costs = $223,320.72 + 276 days X 356 days =
$295,333.56 (1990)
From Julian Date: 0128 to 0007 (1991) = 276 days
Error Rate =0.6
Expiree' Pharmaceuticals Rate = .31
3. (Betts, 1991)
Industry Data:
a. Payback Time = 12 to 18 months
b. Manual Data Entry Error Rate = one per 300 entries
c. Bar Code Scanner Error Rate = one per 3,000,000 entries
4. (Chester and Zilz, 1989)
Ave. Bar Code Device Cost: $1,200 each
Technician Training: 90-minute orientation to the
principles of bar code system
and basic operation of the
device
.
Total inventory time: 342.1 hours/yr




Industry Time savings per technician for inventory: 1 hour/day
(Krause, 1991)
Industry Training Costs: $200-250 per hour
Increased in reporting accuracy: 1% of the total annual costs
Labor Cost in Time: 14 hours/week or 2 hours/day
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APPENDIX F
Pharmaceutical Inventory Reports and Documents
Used for AMAL




3. Asset Location Report
4 Warehouse Picking Ticket and Location Receipt
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